Lewis Joel (CIK 0001725595)

Latest company ownership

Shares held
2,000
Last filed at
Nov 19, 2025
Confidence Score
52.5
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 17, 2025 Dec 19, 2025 GALECTIN THERAPEUTICS INC CEO Sell 47.5 -7,829 -0.93% $55.2K
Nov 17, 2025 Nov 19, 2025 GALECTIN THERAPEUTICS INC CEO Sell 45.0 -22,463 -1.33% $136.4K
Nov 10, 2025 Nov 12, 2025 GALECTIN THERAPEUTICS INC CEO Sell 53.8 -1,867 -0.22% $11.3K
Nov 5, 2025 Nov 7, 2025 GALECTIN THERAPEUTICS INC CEO Sell 58.8 -200 -0.02% $1.2K
Nov 3, 2025 Nov 5, 2025 GALECTIN THERAPEUTICS INC CEO Sell 47.5 -15,720 -0.93% $95.3K
Sep 12, 2025 Sep 15, 2025 GALECTIN THERAPEUTICS INC CEO Sell 45.0 -14,000 -1.65% $89K
Dec 23, 2024 Dec 26, 2024 GALECTIN THERAPEUTICS INC CEO Sell 36.3 -56,000 -5.86% $49.6K
Apr 24, 2024 Apr 25, 2024 GALECTIN THERAPEUTICS INC CEO Buy 55.0 +1,000 0.11% $3.4K
Feb 28, 2023 Mar 2, 2023 GALECTIN THERAPEUTICS INC CEO Sell 42.5 -66,221 -7.47% $156.3K
Feb 16, 2023 Feb 21, 2023 GALECTIN THERAPEUTICS INC CEO Buy 55.0 +1,000 0.11% $1.5K
May 31, 2019 Jun 3, 2019 GALECTIN THERAPEUTICS INC Director Buy 95.0 +12,849 19.53% $55K
Apr 5, 2019 Apr 8, 2019 GALECTIN THERAPEUTICS INC Director Buy 77.5 +667 1.02% $3.2K
Feb 7, 2019 Feb 11, 2019 GALECTIN THERAPEUTICS INC Director Buy 77.5 +1,000 1.56% $4.5K
Jan 29, 2019 Jan 30, 2019 GALECTIN THERAPEUTICS INC Director Buy 77.5 +1,000 1.58% $4.8K
Jun 25, 2018 Jun 26, 2018 GALECTIN THERAPEUTICS INC Director Buy 77.5 +1,000 1.98% $7.1K